These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6395283)

  • 81. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
    Iijima K; Nakamura K
    Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response.
    Kaplan AP; Austen KF
    J Allergy Clin Immunol; 1975 Dec; 56(6):491-506. PubMed ID: 1107395
    [No Abstract]   [Full Text] [Related]  

  • 87. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Alpha 2-macroglobulin-kallikrein potentiates contact system activity: possible effect in asthma.
    Freyria AM; Lasser EC; Lyon SG; Simon RA
    Int Arch Allergy Appl Immunol; 1987; 83(4):341-7. PubMed ID: 2440813
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An autoantibody to human plasma prekallikrein blocks activation of the contact system.
    Page JD; DeLa Cadena RA; Humphries JE; Colman RW
    Br J Haematol; 1994 May; 87(1):81-6. PubMed ID: 7947259
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The inositol-phospholipid-accelerated activation of prekallikrein by activated factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen.
    Schousboe I
    Eur J Biochem; 1990 Oct; 193(2):495-9. PubMed ID: 2226467
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Role of the kallikrein-kininogen-kinin system in the inflammatory reaction and septic shock].
    Hulot M; Ers P; Damas J; Adam A
    Ann Biol Clin (Paris); 1984; 42(1):35-40. PubMed ID: 6233919
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A quarter century with Mr. Hageman.
    Ratnoff OD
    Thromb Haemost; 1980 Jun; 43(2):95-8. PubMed ID: 7006141
    [No Abstract]   [Full Text] [Related]  

  • 95. Human factor XII (Hageman factor).
    Griffin JH; Cochrane CG
    Methods Enzymol; 1976; 45():56-65. PubMed ID: 1012017
    [No Abstract]   [Full Text] [Related]  

  • 96. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibition of contact activation by platelet factor 4.
    Scully MF; Weerasinghe K; Kakkar VV
    Thromb Res; 1980 Nov; 20(4):461-6. PubMed ID: 6163223
    [No Abstract]   [Full Text] [Related]  

  • 98. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 99. The contact system.
    Kitchens CS
    Arch Pathol Lab Med; 2002 Nov; 126(11):1382-6. PubMed ID: 12421145
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Crystalizing our view of the contact system.
    Tucker EI
    Blood; 2020 Oct; 136(14):1576-1577. PubMed ID: 33002124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.